ASSET PURCHASE AGREEMENT WITH TRIMARAN (Details Narrative) |
Aug. 19, 2019
USD ($)
|
|---|---|
| Asset Purchase Agreement [Member] | TRImaran Pharma Inc [Member] | |
| Payment for purchase of assets | $ 100,000 |
| Liabilities assumed | 68,500 |
| Achievement payments payable | 3,400,000 |
| WSU License Agreement [Member] | |
| Reimbursement of patent expenses | $ 75,000 |
| Percentage of third party royalties payable for reduction in royalties payable | 50.00% |
| Maximum percentage reduction of royalties payable | 50.00% |
| Contingent milestone payment obligation | $ 3,400,000 |
| X | ||||||||||
- Definition The amount upon the achievement of specified development, regulatory and sales milestones, Tonix also agreed to pay TRImaran and the Selling Shareholders, in restricted stock or cash, at Tonix’s option per agreement. No definition available.
|
| X | ||||||||||
- Definition The amount of obligation to make contingent milestone payments to Columbia on a Product-by-Product basis upon the achievement of certain development, approval and sales milestones related to a specific products per license agreements. No definition available.
|
| X | ||||||||||
- Definition The maximum percentage by which royalties payable may be reduced. No definition available.
|
| X | ||||||||||
- Definition The percentage of royalties payable to any third party for intellectual property rights which are necessary for the practice of the rights licensed which may reduce royalties payable on net sales. No definition available.
|
| X | ||||||||||
- Definition The amount agreed to pay for reimbursement of patent expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|